Limited Partners
|
Contact Us
About Us
Portfolio
Our Team
News & Events
For Entrepreneurs
Portfolio Company News
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
Aurora News
Newsletters
Events
Speaking Engagements
Portfolio Company News, 2012
December 17
Regado Biosciences, Inc. Secures $51 Million E Series Financing
November 15
Argos Therapeutics Study Confirms Optimal Quality Control Methods for Production of its RNA-Based Immunotherapies
November 14
SEBIO Announces Winners of Regional Deal of the Year Awards
November 2
Southeast BIO Recognizes Argos Therapeutics with the "2012 Southeast BIO Deal of the Year: Venture Capital Transaction" Award
October 11
Unitrends, World’s Fastest Growing Physical and Virtual Backup Appliance Company, Achieves Best Quarter Ever
September 24
HyperBranch Completes Clinical Enrollment
September 7
Gracenote and Digitalsmiths Team to Deliver Enhanced Content Discovery Solution for the Digital Entertainment Market
September 4
Digitalsmiths Seamless Discovery Business Rules Engine Product Overview
September 4
FOX Sports Mobile and Advanced Platforms Expands Relationship with Digitalsmiths
August 1
METABOLON STRENGTHENS METABOLOMICS LEADERSHIP WITH ACQUISITION OF LIPOMICS TECHNOLOGY
July 9
Continuing Expansion, Unitrends Adds Veteran Leadership to Management Team
July 2
Argos Therapeutics Receives FDA Approval of Special Protocol Assessment for AGS-003 Phase 3 Trial
June 11
Argos Therapeutics – Durham drug firm’s early lupus trial shows promise
May 4
Argos Therapeutics – Additional News
May 4
Argos passes on IPO and raises $25m Series D to fund personalized cancer immunotherapy
May 3
Casenet Partners with WellMed Medical Management To Enhance Case Management, Disease Management and Utilization Management Services to Members
May 3
Argos Therapeutics New Release in Journal of Medical Virology
April 24
With IPO Off The Table, Argos Takes $25 Million From VCs
April 24
Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma
April 17
TAKEDA AND METABOLON INITIATE RESEARCH COLLABORATION TO DISCOVER NOVEL TARGETS AND BIOMARKERS
April 10
METABOLON LAUNCHES STRATEGIC OUTSOURCING PROGRAMS FOCUSED ON DISEASE METABOLISM
March 27
METABOLON AWARDED ANALYTICAL METHODS PATENT
March 19
Digitalsmiths Adds Social Media ‘Buzz’ to Entertainment Recommendations
February 4
Argos Therapeutics Announces New Data Demonstrating Prolonged Overall Survival in a Phase 2 Study of its Arcelis™ Immunotherapy AGS-003 in Combination with Sunitinib in Patients with Metastatic Renal Cell Carcinoma (mRCC)
January 31
Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC)
January 26
UNITRENDS EXPERIENCES EXPLOSIVE GROWTH, RECORD BREAKING REVENUE TWO YEARS RUNNING
January 26
Aldagen Presents Data Describing Cell Therapy Products' Mechyanism for Homing to Ischemic Injury
January 25
Argos Therapeutics - New Vaccine Approach Gives Hope to Those Living with HIV
January 10
StrikeIron Wins 2012 Cloud Awards for Cloud Infrastructure and Cloud Computing Company of the Year
About Us
Portfolio
Our Team
News & Events
For Entrepreneurs
©2002–2013 The Aurora Funds, Inc.